Unknown

Dataset Information

0

The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.


ABSTRACT: BACKGROUND:Illicit drug use and associated disease burden are estimated to have increased over the past few decades, but large gaps remain in our knowledge of the extent of use of these drugs, and especially the extent of problem or dependent use, hampering confident cross-national comparisons. The World Mental Health (WMH) Surveys Initiative involves a standardised method for assessing mental and substance use disorders via structured diagnostic interviews in representative community samples of adults. We conducted cross-national comparisons of the prevalence and correlates of drug use disorders (DUDs) in countries of varied economic, social and cultural nature. METHODS AND FINDINGS:DSM-IV DUDs were assessed in 27 WMH surveys in 25 countries. Across surveys, the prevalence of lifetime DUD was 3.5%, 0.7% in the past year. Lifetime DUD prevalence increased with country income: 0.9% in low/lower-middle income countries, 2.5% in upper-middle income countries, 4.8% in high-income countries. Significant differences in 12-month prevalence of DUDs were found across country in income groups in the entire cohort, but not when limited to users. DUDs were more common among men than women and younger than older respondents. Among those with a DUD and at least one other mental disorder, onset of the DUD was usually preceded by the 'other' mental disorder. CONCLUSIONS:Substantial cross-national differences in DUD prevalence were found, reflecting myriad social, environmental, legal and other influences. Nonetheless, patterns of course and correlates of DUDs were strikingly consistent. These findings provide foundational data on country-level comparisons of DUDs.

SUBMITTER: Degenhardt L 

PROVIDER: S-EPMC7370948 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.

Degenhardt Louisa L   Bharat Chrianna C   Glantz Meyer D MD   Sampson Nancy A NA   Scott Kate K   Lim Carmen C W CCW   Aguilar-Gaxiola Sergio S   Al-Hamzawi Ali A   Alonso Jordi J   Andrade Laura H LH   Bromet Evelyn J EJ   Bruffaerts Ronny R   Bunting Brendan B   de Girolamo Giovanni G   Gureje Oye O   Haro Josep Maria JM   Harris Meredith G MG   He Yanling Y   de Jonge Peter P   Karam Elie G EG   Karam Georges E GE   Kiejna Andrzej A   Lee Sing S   Lepine Jean-Pierre JP   Levinson Daphna D   Makanjuola Victor V   Medina-Mora Maria Elena ME   Mneimneh Zeina Z   Navarro-Mateu Fernando F   Posada-Villa José J   Stein Dan J DJ   Tachimori Hisateru H   Torres Yolanda Y   Zarkov Zahari Z   Chatterji Somnath S   Kessler Ronald C RC  

The International journal on drug policy 20190628


<h4>Background</h4>Illicit drug use and associated disease burden are estimated to have increased over the past few decades, but large gaps remain in our knowledge of the extent of use of these drugs, and especially the extent of problem or dependent use, hampering confident cross-national comparisons. The World Mental Health (WMH) Surveys Initiative involves a standardised method for assessing mental and substance use disorders via structured diagnostic interviews in representative community sa  ...[more]

Similar Datasets

| S-EPMC7416527 | biostudies-literature
| S-EPMC2717212 | biostudies-literature
| S-EPMC6008201 | biostudies-literature
| S-EPMC8800240 | biostudies-literature
| S-EPMC5895500 | biostudies-literature
| S-EPMC2705873 | biostudies-literature
| S-EPMC6193834 | biostudies-literature
| S-EPMC5661943 | biostudies-literature
| S-EPMC5333921 | biostudies-literature
| S-EPMC5652513 | biostudies-literature